Not working with any other partner for Covid-19 vaccination, says Pfizer

Clarification comes after a Mumbai-based tour operator announces 'vaccine tourism', solicits customer interest

Pfizer
Sources within the travel industry said the vaccine tourism package could be a ploy to widen customer base
Aneesh Phadnis Mumbai
2 min read Last Updated : Nov 24 2020 | 10:58 PM IST
US drug maker Pfizer has said that it is not working with any other partner at this time or authorised any agency to conduct or facilitate Covid-19 vaccination. The statement came on Tuesday after Gem Tours and Travels, a Mumbai-based tour operator, announced ‘vaccine tourism’ packages for its customers, promising to facilitate Pfizer vaccine shots in the US.
 
"Once approved, Pfizer will supply this vaccine during this pandemic phase only to governments across the world based on agreements with respective government authorities and following regulatory authorisation or approval. Vaccine administration to appropriate populations within a country is a decision for local governments based on relevant health authority guidance," a Pfizer spokesperson said.
 
The Covid-19 vaccine developed by Pfizer along with German firm BioNTech has shown a 95 per cent efficacy against the virus in test results.

Since the Pfizer vaccine requires very low temperatures (-70 degrees Celsius) and is unlikely to be introduced in India, Gem Tours and Travels sensed an opportunity to promote vaccine tourism. In two messages circulated among travel agents, Gem Tours and Travels announced 4 day/3 night packages, including airfare, hotel stay and Covid-19 vaccine shot in the US. The tour operator also said it was not procuring or holding any vaccines while soliciting customer registrations. "Everything we will arrange will be within laws of the US and will be done according to official permission of health department there," it said.
 
Sources within the travel industry said the vaccine tourism package could be a ploy to widen customer base. By gathering customer data, the tour operator could push other domestic and international packages to them, one travel agent said.
 
The tour operator's founder-chairman Jyotin Doshi defended the move stating the company was over three decades old and did not have to resort to such publicity stunts for business.

One subscription. Two world-class reads.

Already subscribed? Log in

Subscribe to read the full story →
*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

Topics :CoronavirusPfizerCoronavirus VaccineCoronavirus Tests

Next Story